Research ArticleClinical Investigations
Early Determination of Prognosis by Interim 3′-Deoxy-3′-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma
Hyewon Lee, Seok-ki Kim, Yong-il Kim, Tae Sung Kim, Se Hun Kang, Weon Seo Park, Tak Yun and Hyeon-Seok Eom
Journal of Nuclear Medicine February 2014, 55 (2) 216-222; DOI: https://doi.org/10.2967/jnumed.113.124172
Hyewon Lee
1Hematology-Oncology Clinic, National Cancer Center, Goyang, South Korea
Seok-ki Kim
2Department of Nuclear Medicine, National Cancer Center, Goyang, South Korea
Yong-il Kim
3Department of Nuclear Medicine, Seoul National University, Seoul, South Korea
Tae Sung Kim
2Department of Nuclear Medicine, National Cancer Center, Goyang, South Korea
Se Hun Kang
4Molecular Imaging and Therapy Branch, National Cancer Center, Goyang, South Korea; and
Weon Seo Park
5Department of Pathology, National Cancer Center, Goyang, South Korea
Tak Yun
1Hematology-Oncology Clinic, National Cancer Center, Goyang, South Korea
Hyeon-Seok Eom
1Hematology-Oncology Clinic, National Cancer Center, Goyang, South Korea

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 2
February 1, 2014
Early Determination of Prognosis by Interim 3′-Deoxy-3′-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma
Hyewon Lee, Seok-ki Kim, Yong-il Kim, Tae Sung Kim, Se Hun Kang, Weon Seo Park, Tak Yun, Hyeon-Seok Eom
Journal of Nuclear Medicine Feb 2014, 55 (2) 216-222; DOI: 10.2967/jnumed.113.124172
Early Determination of Prognosis by Interim 3′-Deoxy-3′-18F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma
Hyewon Lee, Seok-ki Kim, Yong-il Kim, Tae Sung Kim, Se Hun Kang, Weon Seo Park, Tak Yun, Hyeon-Seok Eom
Journal of Nuclear Medicine Feb 2014, 55 (2) 216-222; DOI: 10.2967/jnumed.113.124172